These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Mitogen-activated protein kinases and Hedgehog-GLI signaling in cancer: A crosstalk providing therapeutic opportunities? Rovida E; Stecca B Semin Cancer Biol; 2015 Dec; 35():154-67. PubMed ID: 26292171 [TBL] [Abstract][Full Text] [Related]
43. Targeting GLI factors to inhibit the Hedgehog pathway. Infante P; Alfonsi R; Botta B; Mori M; Di Marcotullio L Trends Pharmacol Sci; 2015 Aug; 36(8):547-58. PubMed ID: 26072120 [TBL] [Abstract][Full Text] [Related]
44. Discovery of potent and novel smoothened antagonists via structure-based virtual screening and biological assays. Lu W; Zhang D; Ma H; Tian S; Zheng J; Wang Q; Luo L; Zhang X Eur J Med Chem; 2018 Jul; 155():34-48. PubMed ID: 29857275 [TBL] [Abstract][Full Text] [Related]
45. Bicyclic Imidazolium Inhibitors of Gli Transcription Factor Activity. Hom ME; Ondrus AE; Sakata-Kato T; Rack PG; Chen JK ChemMedChem; 2020 Jun; 15(12):1044-1049. PubMed ID: 32268014 [TBL] [Abstract][Full Text] [Related]
46. Regulation of Gli ciliary localization and Hedgehog signaling by the PY-NLS/karyopherin-β2 nuclear import system. Han Y; Xiong Y; Shi X; Wu J; Zhao Y; Jiang J PLoS Biol; 2017 Aug; 15(8):e2002063. PubMed ID: 28777795 [TBL] [Abstract][Full Text] [Related]
47. Cooperative integration between HEDGEHOG-GLI signalling and other oncogenic pathways: implications for cancer therapy. Pandolfi S; Stecca B Expert Rev Mol Med; 2015 Feb; 17():e5. PubMed ID: 25660620 [TBL] [Abstract][Full Text] [Related]
48. The Hedgehog signalling pathway mediates drug response of MCF-7 mammosphere cells in breast cancer patients. He M; Fu Y; Yan Y; Xiao Q; Wu H; Yao W; Zhao H; Zhao L; Jiang Q; Yu Z; Jin F; Mi X; Wang E; Cui Z; Fu L; Chen J; Wei M Clin Sci (Lond); 2015 Nov; 129(9):809-22. PubMed ID: 26201092 [TBL] [Abstract][Full Text] [Related]
49. Suppression of GLI sensitizes medulloblastoma cells to mitochondria-mediated apoptosis. Lin Z; Li S; Sheng H; Cai M; Ma LY; Hu L; Xu S; Yu LS; Zhang N J Cancer Res Clin Oncol; 2016 Dec; 142(12):2469-2478. PubMed ID: 27601167 [TBL] [Abstract][Full Text] [Related]
50. Identification of Nedd4 as a novel regulator in Hedgehog signaling. Luo QF; Chen W; Zhang ST Chin Med J (Engl); 2012 Nov; 125(21):3851-5. PubMed ID: 23106887 [TBL] [Abstract][Full Text] [Related]
52. Digging a hole under Hedgehog: downstream inhibition as an emerging anticancer strategy. Di Magno L; Coni S; Di Marcotullio L; Canettieri G Biochim Biophys Acta; 2015 Aug; 1856(1):62-72. PubMed ID: 26080084 [TBL] [Abstract][Full Text] [Related]
53. Inhibition of hedgehog/Gli signaling by botanicals: a review of compounds with potential hedgehog pathway inhibitory activities. Drenkhahn SK; Jackson GA; Slusarz A; Starkey NJ; Lubahn DB Curr Cancer Drug Targets; 2013 Jun; 13(5):580-95. PubMed ID: 23675897 [TBL] [Abstract][Full Text] [Related]
54. Novel 4-(2-pyrimidinylamino)benzamide derivatives as potent hedgehog signaling pathway inhibitors. Xin M; Zhang L; Tu C; Tang F; Wen J Bioorg Med Chem; 2018 Oct; 26(18):5029-5036. PubMed ID: 30249494 [TBL] [Abstract][Full Text] [Related]
55. Hedgehog inhibitors from Artocarpus communis and Hyptis suaveolens. Arai MA; Uchida K; Sadhu SK; Ahmed F; Koyano T; Kowithayakorn T; Ishibashi M Bioorg Med Chem; 2015 Aug; 23(15):4150-4154. PubMed ID: 26178912 [TBL] [Abstract][Full Text] [Related]
56. Design and Evolution of a Macrocyclic Peptide Inhibitor of the Sonic Hedgehog/Patched Interaction. Owens AE; de Paola I; Hansen WA; Liu YW; Khare SD; Fasan R J Am Chem Soc; 2017 Sep; 139(36):12559-12568. PubMed ID: 28759213 [TBL] [Abstract][Full Text] [Related]
57. Structure-based virtual screening identifies an 8-hydroxyquinoline as a small molecule GLI1 inhibitor. Dash RC; Wen J; Zaino AM; Morel SR; Chau LQ; Wechsler-Reya RJ; Hadden MK Mol Ther Oncolytics; 2021 Mar; 20():265-276. PubMed ID: 33614910 [TBL] [Abstract][Full Text] [Related]
58. Synthesis and evaluation of hedgehog signaling inhibitor with novel core system. Ohashi T; Tanaka Y; Shiokawa Z; Banno H; Tanaka T; Shibata S; Satoh Y; Yamakawa H; Yamamoto Y; Hattori H; Kondo S; Miyamoto M; Tojo H; Baba A; Sasaki S Bioorg Med Chem; 2015 Aug; 23(15):4777-4791. PubMed ID: 26094943 [TBL] [Abstract][Full Text] [Related]
59. Identification of vitamin d3-based hedgehog pathway inhibitors that incorporate an aromatic a-ring isostere. DeBerardinis AM; Banerjee U; Hadden MK ACS Med Chem Lett; 2013 Jul; 4(7):590-5. PubMed ID: 24900716 [TBL] [Abstract][Full Text] [Related]
60. Macrocyclic Hedgehog Pathway Inhibitors: Optimization of Cellular Activity and Mode of Action Studies. Dockendorff C; Nagiec MM; Weïwer M; Buhrlage S; Ting A; Nag PP; Germain A; Kim HJ; Youngsaye W; Scherer C; Bennion M; Xue L; Stanton BZ; Lewis TA; Macpherson L; Palmer M; Foley MA; Perez JR; Schreiber SL ACS Med Chem Lett; 2012 Oct; 3(10):808-813. PubMed ID: 23074541 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]